Pigeon Lovers' lung disease: genes may hold the key
NCT ID NCT03747627
First seen Jun 27, 2026 ยท Last updated Jun 27, 2026
Summary
This study looked at whether certain genes make people who are regularly around pigeons more likely to develop a type of lung disease called hypersensitivity pneumonitis. Researchers analyzed the DNA of 475 pigeon fanciers to find genetic markers linked to lung scarring. The goal is to better understand why some people get sick and others don't, which could lead to earlier detection or new treatments.
What this could mean
Our plain-language read of the trial. This is informational only โ not medical advice or a prediction.
- What this could lead to
- If successful, this study could help identify who is at higher risk for pigeon-related lung disease and point toward better prevention or treatment strategies.
- What could go wrong
- This is an observational genetic study, not a treatment trial. It may not lead directly to new therapies, and findings may not apply to the general population.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for ALVEOLITIS, EXTRINSIC ALLERGIC are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
Royal Pigeon Racing Association Meeting
Blackpool, FY1 1HL, United Kingdom
-
Scottish Homing Union
Lanark, ML11 9AX, United Kingdom
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Can a new pill slow lung scarring in IPF?
- Beyond the lungs: the hidden emotional toll of IPF medications
- Can umbilical cord stem cells ease a scarring lung disease?
- Spotting hidden blood clots in scarred lungs: a study hunts for clues
- What makes someone stop a lung fibrosis drug? a study asks patients directly
- A smarter way to track lung disease? new platform aims to personalize COPD and IPF care